Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium.
暂无分享,去创建一个
David C. Miller | T. Morgan | J. Montie | S. Kaffenberger | S. Linsell | B. Lane | J. Peabody | M. Cher | F. Abdollah | J. Qi | A. Loeb | Hernan Lescay
[1] J. Montie,et al. Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups , 2019, The Journal of urology.
[2] G. Bratslavsky,et al. Is pelvic lymph node dissection necessary in patients with biopsy proven Gleason 6 prostate cancer? - analysis of the SEER database. , 2018, The Canadian journal of urology.
[3] F. Montorsi,et al. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. , 2017, Urologic oncology.
[4] Sinae Kim,et al. Utilization of Pelvic Lymph Node Dissection for Patients With Low‐Risk Prostate Cancer Treated With Robot‐Assisted Radical Prostatectomy , 2017, Clinical genitourinary cancer.
[5] M. Menon,et al. Rate and Extent of Pelvic Lymph Node Dissection in the US Prostate Cancer Patients Treated With Radical Prostatectomy , 2017, Clinical genitourinary cancer.
[6] Vidit Sharma,et al. Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer , 2017, Current Urology Reports.
[7] H. G. van der Poel,et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. , 2017, European urology.
[8] H. G. van der Poel,et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.
[9] C. Kwak,et al. Extended versus Standard Pelvic Lymph Node Dissection in Radical Prostatectomy on Oncological and Functional Outcomes: A Systematic Review and Meta-Analysis , 2017, Annals of Surgical Oncology.
[10] A. Haese*,et al. Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] W. Lowrance,et al. Gleason 6 Prostate Cancer: Translating Biology into Population Health. , 2015, The Journal of urology.
[12] C. Gross,et al. Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database. , 2015, The Journal of urology.
[13] H. G. van der Poel,et al. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions. , 2014, European urology.
[14] B. Guillonneau,et al. Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: practice patterns of uro-oncologists in North America. , 2013, Urologic oncology.
[15] F. Montorsi,et al. Pelvic lymph node dissection for prostate cancer: Adherence and accuracy of the recent guidelines , 2013, International journal of urology : official journal of the Japanese Urological Association.
[16] A. Briganti,et al. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection. , 2012, Urology.
[17] Andrea Salonia,et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. , 2006, European urology.
[18] B. Konety,et al. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. , 2006, Urology.
[19] David C. Miller,et al. Appropriateness Criteria for Active Surveillance of Prostate Cancer , 2017, The Journal of urology.